ClinicalTrials.gg
RecruitingNCT05961176Updated Oct 21, 2026

Exploratory Study on Bio-signal Telemonitoring Using Electronic Textiles in a Pediatric Acute and Critical Care Setting

An observational study in Heart Failure, sponsored by The Hospital for Sick Children. Recruiting at 1 site in Canada. Open to participants aged 1 Month to 12 Years. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by The Hospital for Sick Children · Observational

How we know

From the registry’s dates

  • Started Jan 2024; still recruiting 2 years 10 months later.
Updated Oct 21, 2026Primary completion movedStudy completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
1 Month to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 454 studies in Heart Failure with a site in Canada — 77 open to participants now, 99 under way, 21 of them phase 3. Heart Failure · Canada.

Planned enrollment
68th of 91
100 · median 360
Started
2024
with 26 others
Observational
92 of 454
16 open now
Primary completion
2027-12
later than 63 of 98 live
Registered
397th of 454
by date

Among the 454 studies in Heart Failure with a site in Canada, this one is the 68th largest by planned enrollment of the 91 observational ones that give a count, is one of 27 that started in 2024, is one of 92 observational ones, reaches primary completion later than 63 of the 98 other live ones, and was the 397th registered.

Heart Failure

6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.

Browse Heart Failure studies →

Open to participants now

77 of the 454 studies in Heart Failure with a site in Canada are open now. Recruiting first, the newest first:

72 more — sign in →

All 77 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.

This study: 1 Month to 12 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 454 studies in Heart Failure with a site in Canada, or all of them as a file.
02

Study summary

The primary research objective is to determine the safety, feasibility, usability and validity of textile-enabled monitoring systems designed to capture physiologic variables, or "biological signals," related to cardiopulmonary function in children through comparison to hospital-based, standard-of-care monitoring in the Sickkids Cardiac Critical Care Unit (CCCU).

Read the detailed description

This single-arm, non-randomized study is a usability, technology feasibility and data correlation study which will employ a convenience sampling method. The study will compare the quality of data obtained by the Myant Inc Skiin Pediatric Band smart textile device to the gold-standard data generated by the clinical devices in the CCCU at SickKids.

The primary research objective is to determine the safety, feasibility, usability and validity of textile-enabled monitoring systems designed to capture physiologic variables, or "biological signals," related to cardiopulmonary function in children through comparison to hospital-based, standard-of-care monitoring in the SickKids CCCU.

The secondary objectives are as follows; (1) To design textiles for infants and children that allow safe, developmentally appropriate care, (2) To investigate the optimum placement of biosensors to measure physiologic parameters such as heart and respiratory rate within the textile-based approach, (3) To validate the textile-based approach, including the integrated sensors, through comparison to physiologic data gathered as part of routine patient care through traditional comparative analysis, (4) To investigate usability of the textiles, including placement, removal, and effects on patient care activities, and (5) To gather clinician feedback on the textile use and design.

03

Conditions studied

  • Heart Failure

Keywords

  • Wearable Electronic Device
  • Cardiovascular Disease
  • Critical Care
  • Pediatric
04

Who can participate

Ages eligible
1 Month to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Infants and Children Admitted to the Cardiac Critical Care Unit

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

1. Patients from 1 month of age to 12 years of age who are admitted to SickKids CCCU with expected stays in CCCU longer than 12 hours including those for medical management and post-surgical patients.

Exclusion criteria

Exclusion Criteria:

  1. Any existing condition, diagnosis or physiologic state, in the opinion of the principal investigator, Co-Investigators or most responsible physicians, in which presence of the study monitoring system may have negative effects on patient status or may impair care delivered by the treating team (e.g. hemodynamic instability, at risk for acute deterioration in condition).
  2. Patients with active wounds or devices (such as a chest tube or invasive lines) in areas that prohibit placement of all configurations of textile device. *
  3. Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) that represent an infection control risk.
  4. Patients cannulated to extracorporeal membrane oxygenation (ECMO).
  5. Patients with imaging/procedures scheduled outside of the CCCU within the 12 hours following eligibility assessment. **
  6. Patients with an implanted cardioverter defibrillator (ICD)
  7. Patients with a pacemaker, either implanted or temporary (temporary pacing wires not in use are allowed). ***
  8. Patients whose chest/abdomen size is too large or small to fit the available sizes of the Skiin Pediatric Band.

Eligibility may be reassessed once an appropriate body location for the textile placement becomes available.*

Eligibility may be reassessed after the patient returns to the CCCU.**

Eligibility may be reassessed after the temporary pacemaker has been removed.***

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Infants and Children Admitted to the CCCU at SickKids

    Inclusion Criteria: Patients from 1 month of age to 12 years of age who are admitted to SickKids CCCU with expected stays in CCCU longer than 12 hours including those for medical management and post-surgical patients.

    Device: Skiin pediatric band and Skiin biometric pod

Interventions

  • DeviceSkiin pediatric band and Skiin biometric pod

    Infants that meet the inclusion criteria will be equipped with a Skiin pediatric band appropriate for their chest size. Heart rate, respiratory rate, temperature, and electrocardiogram will be monitored from 2 to 12 hours through the Skiin pediatric band and a standard of care device (Phillips Intellivue MX750) commonly used in the CCCU at SickKids.

06

What researchers measure

Primary outcomes

  1. Heart Rate

    The difference between heart rate measured from Skiin data and from standard of care device.

    Time frame: collection during the single study session of 2-12 hours.

  2. Respiratory Rate

    The difference between respiratory rate measured from Skiin data and from standard of care device.

    Time frame: collection during the single study session of 2-12 hours.

  3. Temperature

    The difference between temperature measured from Skiin data and from standard of care device.

    Time frame: collection during the single study session of 2-12 hours.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Andrews RE, Fenton MJ, Ridout DA, Burch M; British Congenital Cardiac Association. New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United kingdom and Ireland. Circulation. 2008 Jan 1;117(1):79-84. doi: 10.1161/CIRCULATIONAHA.106.671735. Epub 2007 Dec 17. PubMed 18086928 ↗
  • Wilkinson JD, Landy DC, Colan SD, Towbin JA, Sleeper LA, Orav EJ, Cox GF, Canter CE, Hsu DT, Webber SA, Lipshultz SE. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin. 2010 Oct;6(4):401-13, vii. doi: 10.1016/j.hfc.2010.05.002. PubMed 20869642 ↗
  • Kay JD, Colan SD, Graham TP Jr. Congestive heart failure in pediatric patients. Am Heart J. 2001 Nov;142(5):923-8. doi: 10.1067/mhj.2001.119423. No abstract available. PubMed 11685182 ↗
  • Nandi D, Rossano JW. Epidemiology and cost of heart failure in children. Cardiol Young. 2015 Dec;25(8):1460-8. doi: 10.1017/S1047951115002280. PubMed 26675591 ↗
  • Jacob E, Duran J, Stinson J, Lewis MA, Zeltzer L. Remote monitoring of pain and symptoms using wireless technology in children and adolescents with sickle cell disease. J Am Assoc Nurse Pract. 2013 Jan;25(1):42-54. doi: 10.1111/j.1745-7599.2012.00754.x. Epub 2012 Jul 12. PubMed 23279278 ↗
  • Zartner P, Handke R, Photiadis J, Brecher AM, Schneider MB. Performance of an autonomous telemonitoring system in children and young adults with congenital heart diseases. Pacing Clin Electrophysiol. 2008 Oct;31(10):1291-9. doi: 10.1111/j.1540-8159.2008.01180.x. PubMed 18811810 ↗
  • Zartner PA, Toussaint-Goetz N, Photiadis J, Wiebe W, Schneider MB. Telemonitoring with implantable electronic devices in young patients with congenital heart diseases. Europace. 2012 Jul;14(7):1030-7. doi: 10.1093/europace/eur434. Epub 2012 Feb 2. PubMed 22308087 ↗
  • Ware P, Ross HJ, Cafazzo JA, Laporte A, Seto E. Implementation and Evaluation of a Smartphone-Based Telemonitoring Program for Patients With Heart Failure: Mixed-Methods Study Protocol. JMIR Res Protoc. 2018 May 3;7(5):e121. doi: 10.2196/resprot.9911. PubMed 29724704 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Dec 2027, 47 months after the start.

Of 799 non-industry observational studies under Heart Failure, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 100. This study's planned 47 months is close to that.

Counting every sponsor, half of 982 studies reached it within 41 months; a quarter within 23 and three quarters within 89.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 21, 2026: primary completion Jan 2025 → Dec 2027 and completion Jan 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 18, 2023
First posted
Jul 27, 2023
StartActual
Jan 17, 2024
Primary completionEst.
Dec 30, 2027was Jan 2025
CompletionEst.
Dec 30, 2027was Jan 2026
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jan 17, 2025→Dec 30, 2027
Oct 21, 2026
Study completion
Jan 17, 2026→Dec 30, 2027
Oct 21, 2026
Contact
Study contact changed: a•••@sickkids.ca · •••7500→d•••@sickkids.ca · •••7500. See the current contact
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    Primary completion Jan 17, 2025→Dec 30, 2027
    Study completion Jan 17, 2026→Dec 30, 2027
    Contact Study contact changed: a•••@sickkids.ca · •••7500→d•••@sickkids.ca · •••7500. See the current contact
    + 4 other changes: verification date, criteria formatting, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05961176
Collaborators
Myant Medical Corp.
Responsible party
Aamir Jeewa (Staff Cardiologist, The Hospital for Sick Children) — Principal investigator
First posted
Jul 27, 2023
Start date
Jan 17, 2024
Primary completion
Dec 30, 2027 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Oct 21, 2026

Study contacts

Diana Balmer-Minnes
Contact
diana.balmer-minnes@sickkids.ca
416-813-7500 ext. 228624
Aamir Jeewa, MD
Contact
aamir.jeewa@sickkids.ca
Aamir Jeewa, MD
principal investigator · The Hospital for Sick Children
Michael-Alice Moga, MD
principal investigator · The Hospital for Sick Children

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion